Treatment of Drug-Resistant Tuberculosis. an Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
Payam Nahid, Sundari R. Mase,Giovanni Battista Migliori,Giovanni Sotgiu,Graham H. Bothamley,Jan L. Brozek,Adithya Cattamanchi,J. Peter Cegielski,Lisa Chen,Charles L. Daley,Tracy L. Dalton,Raquel Duarte,Federica Fregonese,C. Robert Horsburgh,Faiz Ahmad Khan,Fayez Kheir,Zhiyi Lan,Alfred Lardizabal,Michael Lauzardo,Joan M. Mangan,Suzanne M. Marks,Lindsay McKenna,Dick Menzies,Carole D. Mitnick,Diana M. Nilsen,Farah Parvez,Charles A. Peloquin,Ann Raftery,H. Simon Schaaf,Neha S. Shah,Jeffrey R. Starke,John W. Wilson,Jonathan M. Wortham,Terence Chorba,Barbara Seaworth American Journal of Respiratory and Critical Care Medicine（2019）
Key words
MDR-TB,tuberculosis,duration of treatment,drug treatment,treatment monitoring
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper